Your browser doesn't support javascript.
loading
Tailoring translational strength using Kozak sequence variants improves bispecific antibody assembly and reduces product-related impurities in CHO cells.
Blanco, Noelia; Williams, Ambrose J; Tang, Danming; Zhan, Dejin; Misaghi, Shahram; Kelley, Robert F; Simmons, Laura C.
Afiliación
  • Blanco N; Departments of Cell Culture, Genentech, Inc., 1 DNA Way, South San Francisco, California.
  • Williams AJ; Departments of Purification Development, Genentech, Inc., 1 DNA Way, South San Francisco, California.
  • Tang D; Departments of Cell Culture, Genentech, Inc., 1 DNA Way, South San Francisco, California.
  • Zhan D; Departments of Cell Culture, Genentech, Inc., 1 DNA Way, South San Francisco, California.
  • Misaghi S; Departments of Cell Culture, Genentech, Inc., 1 DNA Way, South San Francisco, California.
  • Kelley RF; Departments of Drug Delivery, Genentech, Inc., 1 DNA Way, South San Francisco, California.
  • Simmons LC; Departments of Cell Culture, Genentech, Inc., 1 DNA Way, South San Francisco, California.
Biotechnol Bioeng ; 117(7): 1946-1960, 2020 07.
Article en En | MEDLINE | ID: mdl-32246763
ABSTRACT
Optimal production of bispecific antibodies (bsAb) requires efficient and tailored co-expression and assembly of two distinct heavy and two distinct light chains. Here, we describe a novel technology to modulate the translational strength of antibody chains via Kozak sequence variants to produce bsAb in a single cell line. In this study, we designed and screened a large Kozak sequence library to identify 10 independent variants that can modulate protein expression levels from approximately 0.2 to 1.3-fold compared with the wild-type sequence in transient transfection. We used a combination of several of these variants, covering a wide range of translational strength, to develop stable single cell Chinese hamster ovary bispecific cell lines and compared the results with those obtained from the wild-type sequence. A significant increase in bispecific antibody assembly with a concomitant reduction in the level of product-related impurities was observed. Our findings suggest that for production of bsAb it can be advantageous to modify translational strength for selected protein chains to improve overall yield and product quality. By extension, tuning of translational strength can also be applied to improving the production of a wide variety of heterologous proteins.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Biotechnol Bioeng Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Biotechnol Bioeng Año: 2020 Tipo del documento: Article